| Name: | Cefixime EP Impurity B |
| Catalogue No. | VE007701 |
| CAS No. | 1335475-19-8 |
| Molecular Formula | C15H17N5O6S2 |
| Molecular Weight | 427.46 g/mol |
| Status | In-Stock |
| IUPAC Name | 2-[[[(Z)-1-(2-Aminothiazol-4-yl)-2-[[[(2R,5RS)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]methyl]amino]-2-oxoethylidene] amino]oxy]acetic acid |
| Description | Cefixime EP Impurity B (CAS No: 1335475-19-8) Or 2-[[[(Z)-1-(2-Aminothiazol-4-yl)-2-[[[(2R,5RS)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]methyl]amino]-2-oxoethylidene] amino]oxy]acetic acid, Cefixime EP Impurity B is an impurity of Cefixime,which is effective against bacteria causing infection of the ear, throat, urinary tract, gonorrhea, and pneumonia. |
| References | Sci-Hub | A conventional HPLC-MS method for the simultaneous determination of ofloxacin and cefixime in plasma: Development and validation | 10.4103/0976-0105.113606. (2013). Retrieved January 11, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.4103/0976-0105.113606 |
